Zobrazeno 1 - 2
of 2
pro vyhledávání: '"DMD, disease modifying drug"'
Publikováno v:
EBioMedicine, Vol 16, Iss C, Pp 41-50 (2017)
EBioMedicine
EBioMedicine
Although multiple sclerosis (MS) is considered to be a CD4, Th17-mediated autoimmune disease, supportive evidence is perhaps circumstantial, often based on animal studies, and is questioned by the perceived failure of CD4-depleting antibodies to cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca69af1819ed91cfbe5f89c22fa991d
Autor:
Yossan‑Var Tan, James A. Waschek
Publikováno v:
ASN Neuro, Vol 3 (2011)
ASN NEURO
ASN NEURO
MS (multiple sclerosis) is a chronic autoimmune and neurodegenerative pathology of the CNS (central nervous system) affecting approx. 2.5 million people worldwide. Current and emerging DMDs (disease-modifying drugs) predominantly target the immune sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f748190b08c1d26b9f1f491e1886984
https://doaj.org/article/e64728eaced048cd929fc072750ee04b
https://doaj.org/article/e64728eaced048cd929fc072750ee04b